WB result of S-RMabMix™ Pyruvyl Lysine Rabbit mAb
Primary antibody: S-RMabMix™ Pyruvyl Lysine Rabbit mAb at 1/1000 dilution
Lane 1: HeLa whole cell lysate 40 µg
Secondary antibody: Goat Anti-Rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: Multiple
Observed MW: Multiple
This blot was developed with high sensitivity substrate
Product Details
Product Details
Product Specification
| Synonyms | Pyruvylation; Kpy; pyruvylated |
| Immunogen | Synthetic Peptide |
| Antibody Type | Recombinant mAb Mix |
| Isotype | IgG |
| Application | WB |
| Reactivity | Species Independent |
| Purification | Protein A |
| Concentration | 2 mg/ml |
| Conjugation | Unconjugated |
| Physical Appearance | Liquid |
| Storage Buffer | PBS, 40% Glycerol, 0.05% BSA, 0.02% sodium azide |
| Stability & Storage | 12 months from date of receipt / reconstitution, -20 °C as supplied |
Dilution
| application | dilution | species |
| Dot Blot | 1:1000 | Species Independent |
| WB | 1:1000 | Species Independent |
Background
Lysine pyruvylation (Kpy) is a novel post-translational modification driven by the central glycolytic metabolite pyruvate, in which a pyruvoyl group is covalently attached to the ε-amino group of a lysine residue. This dynamic modification is regulated by the writer enzymes HAT1 and p300, and the eraser enzyme SIRT3. By coupling glycolytic flux to protein function, Kpy plays a pivotal role in epigenetic regulation and transcriptional activation, while also mediating metabolic-immune crosstalk, such as inhibiting type I interferon signaling under high-glucose conditions.
Picture
Picture
Western Blot
WB result of S-RMabMix™ Pyruvyl Lysine Rabbit mAb
Primary antibody: S-RMabMix™ Pyruvyl Lysine Rabbit mAb at 1/1000 dilution
Lane 1: mouse liver lysate 40 µg
Secondary antibody: Goat Anti-Rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: Multiple
Observed MW: Multiple
This blot was developed with high sensitivity substrate
Dot Blot
Dot blot result of S-RMabMix™ Pyruvyl Lysine Rabbit mAb
Lane 1: Modified peptide library (Pyruvoyl lysine)
Lane 2: Unmodified peptide library control
Lane 3: Modified peptide library (L-lactyl lysine)
Lane 4: Modified peptide library (Fumaryl lysine)
Lane 5: Modified peptide library (Crotonyl lysine)
Lane 6: Modified peptide library (Succinyl lysine)
Lane 7: Modified peptide library (Butyryl lysine)
Lane 8: Modified peptide library (Propionyl lysine)
Lane 9: Modified peptide library (Actyl lysine)
Lane 10: Pyruvoyl lysine modified peptied sequence 1
Lane 11: Pyruvoyl lysine unmodified peptied sequence control 1
Lane 12: Pyruvoyl lysine modified peptied sequence 2
Lane 13: Pyruvoyl lysine unmodified peptied sequence control 2
Lane 14: Pyruvoyl lysine modified peptied sequence 3
Lane 15: Pyruvoyl lysine unmodified peptied sequence control 3
Lane 16: Pyruvoyl lysine modified peptied sequence 4
Lane 17: Pyruvoyl lysine unmodified peptied sequence control 4
Primary antibody: S-RMabMix™ Pyruvyl Lysine Rabbit mAb at 1/1000 dilution
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
